The future of immunotherapy in multiple myeloma
Hearn Cho et al.
A new era of treatment for elderly acute myeloid leukemia (AML) patients?
Hagop M. Kantarjian
The regulation of biosimilars
New strategies in AML: checkpoint inhibitors combined with T-cell engagers
Cytokine storms: CAR T-cell hyperinflammatory response distinct from cytokine release syndrome?